In these latter cases, AAT level testing alone is not recommended because it does not fully characterise disease risk from AATD although some guidelines advocate both AAT plasma levels and genotype for at least the S and Z alleles as initial testing [32–34]. Here, SERPINA1 is linked to alpha 1-antitrypsin deficiency.